19-11021968-G-C
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_003072.5(SMARCA4):c.2859+1G>C variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_003072.5 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.2859+1G>C | splice_donor_variant, intron_variant | Intron 19 of 35 | ENST00000646693.2 | NP_001374212.1 | ||
SMARCA4 | NM_003072.5 | c.2859+1G>C | splice_donor_variant, intron_variant | Intron 19 of 34 | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.2859+1G>C | splice_donor_variant, intron_variant | Intron 19 of 35 | NM_001387283.1 | ENSP00000495368.1 | ||||
SMARCA4 | ENST00000344626.10 | c.2859+1G>C | splice_donor_variant, intron_variant | Intron 19 of 34 | 1 | NM_003072.5 | ENSP00000343896.4 | |||
SMARCA4 | ENST00000643549.1 | c.2859+1G>C | splice_donor_variant, intron_variant | Intron 19 of 34 | ENSP00000493975.1 | |||||
SMARCA4 | ENST00000541122.6 | c.2859+1G>C | splice_donor_variant, intron_variant | Intron 20 of 34 | 5 | ENSP00000445036.2 | ||||
SMARCA4 | ENST00000643296.1 | c.2859+1G>C | splice_donor_variant, intron_variant | Intron 19 of 33 | ENSP00000496635.1 | |||||
SMARCA4 | ENST00000644737.1 | c.2859+1G>C | splice_donor_variant, intron_variant | Intron 19 of 33 | ENSP00000495548.1 | |||||
SMARCA4 | ENST00000589677.5 | c.2859+1G>C | splice_donor_variant, intron_variant | Intron 20 of 34 | 5 | ENSP00000464778.1 | ||||
SMARCA4 | ENST00000643995.1 | c.2271+1G>C | splice_donor_variant, intron_variant | Intron 16 of 31 | ENSP00000496004.1 | |||||
SMARCA4 | ENST00000644963.1 | c.1503+1G>C | splice_donor_variant, intron_variant | Intron 12 of 27 | ENSP00000495599.1 | |||||
SMARCA4 | ENST00000644065.1 | c.1584+1G>C | splice_donor_variant, intron_variant | Intron 12 of 26 | ENSP00000493615.1 | |||||
SMARCA4 | ENST00000642350.1 | c.1344+1G>C | splice_donor_variant, intron_variant | Intron 11 of 26 | ENSP00000495355.1 | |||||
SMARCA4 | ENST00000643857.1 | c.1212+1G>C | splice_donor_variant, intron_variant | Intron 10 of 24 | ENSP00000494159.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.2859+1G>C intronic variant results from a G to C substitution one nucleotide after coding exon 18 of the SMARCA4 gene. This alteration has been identified in two individuals diagnosed with small cell carcinoma of the ovary, hypercalcemic type from one family, and this alteration was found to cause skipping of exon 19 (Witkowski L et al. Fam. Cancer, 2017 07;16:395-399). This nucleotide position is highly conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to abolish the native splice donor site; however, direct evidence is unavailable. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at